Cargando…
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
The road to low-dose aspirin therapy for the prevention of preeclampsia began in the 1980s with the discovery that there was increased thromboxane and decreased prostacyclin production in placentas of preeclamptic women. At the time, low-dose aspirin therapy was being used to prevent recurrent myoca...
Autores principales: | Walsh, Scott W., Strauss, Jerome F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268135/ https://www.ncbi.nlm.nih.gov/pubmed/34209594 http://dx.doi.org/10.3390/ijms22136985 |
Ejemplares similares
-
Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy
por: Stephenson, Daniel J., et al.
Publicado: (2023) -
Aspirin for Prevention of Preeclampsia
por: Atallah, A., et al.
Publicado: (2017) -
Aspirin Inhibits the Inflammatory Response of Protease-Activated Receptor 1 in Pregnancy Neutrophils: Implications for Treating Women with Preeclampsia
por: Walsh, Scott W., et al.
Publicado: (2022) -
Aspirin for Prevention of Preeclampsia in Lupus Pregnancy
por: Schramm, Amelie M., et al.
Publicado: (2014) -
Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study
por: Zhou, Qiongjie, et al.
Publicado: (2023)